Anti-Glucose Transporter GLUT1 Antibody (A284052)

Anti-Glucose Transporter GLUT1 Antibody

Rabbit polyclonal antibody to Glucose Transporter GLUT1.

This antibody recognises human Solute carrier family 2, facilitated glucose transporter member 1, also known as GLUT-1, glucose transporter type 1, erythrocyte/brain or HepG2 glucose transporter. GLUT-1 is a 492 amino acid ~50 kDa multi-pass transmembrane glycoprotein involved in cellular uptake of glucose.Mutations in the GLUT1 gene can lead to a number of chronic conditions including GLUT1 deficiency syndrome 1 (GLUT1DS1), a neurologic disorder with wide phenotypic variability , GLUT1 deficiency syndrome 2 (GLUT1DS2), characterized by juvenile onset of excercise-induced dyskinesia , Epilepsy, idiopathic generalized 12 (EIG12) a condition presenting with repeated generalized seizures and Dystonia 9 (DYT9) a dominant inherited disorder presenting as a childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia.

WB, IP

IP: 1 - 10 µg/ml, WB: 1 - 10 µg/ml

Human, Mouse, Rat, Bovine, Cat, Dog, Horse, Pig, Rabbit, Rhesus Monkey, Sheep

A peptide sequence of LFHPLGADSQV from the C-terminus of hGLUT-1 conjugated to Keyhole Limpet Haemocyanin.

LFHPLGADSQV

Rabbit

Polyclonal

IgG

Unconjugated

Affinity chromatography.

Liquid

Supplied in Phosphate Buffered Saline with 0.1% Sodium Azide.

Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.

Rabbit anti Human glucose transporter-1 antibody recognizes human Solute carrier family 2, facilitated glucose transporter member 1, also known as GLUT-1, glucose transporter type 1, erythrocyte/brain or HepG2 glucose transporter. GLUT-1 is a 492 amino acid ~50 kDa multi-pass transmembrane glycoprotein involved in cellular uptake of glucose.Mutations in the GLUT1 gene can lead to a number of chronic conditions including GLUT1 deficiency syndrome 1 (GLUT1DS1), a neurologic disorder with wide phenotypic variability (Wang et al. 2005), GLUT1 deficiency syndrome 2 (GLUT1DS2), characterized by juvenile onset of excercise-induced dyskinesia (Weber et al. 2008), Epilepsy, idiopathic generalized 12 (EIG12) a condition presenting with repeated generalized seizures (Stranio et al. 2012) and Dystonia 9 (DYT9) a dominant inherited disorder presenting as a childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia (Weber et al. 2011).

Choreoathetosis/spasticity episodic (paroxysmal choreoathetosis/spasticity), CSE, DYT17, DYT18, DYT9, EIG12, erythrocyte/brain, Erythrocyte/hepatoma glucose transporter, facilitated glucose transporter member 1, Glucose transporter 1, Glucose transporter type 1, Glucose transporter type 1, erythrocyte/brain, GLUT, GLUT-1, GLUT1, GLUT1DS, GLUTB, GT1, GTG1, Gtg3, GTR1_HUMAN, HepG2 glucose transporter, HTLVR, Human T cell leukemia virus (I and II) receptor, MGC141895, MGC141896, PED, RATGTG1, Receptor for HTLV 1 and HTLV 2, SLC2A1, Solute carrier family 2, Solute carrier family 2 (facilitated glucose transporter), member 1, Solute carrier family 2, facilitated glucose transporter member 1